MeSH Browser

MeSH Supplementary: belnacasan
Unique ID: C520022
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C520022
Entry Term(s): (S)-1-((S)-2-1((-(4-amino-3-chloro-phenyl)-methanoyl)-amino)-3,3-dimethyl-butanoyl)-pyrrolidine-2-carboxylic acid ((2R,3S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide; (S)-3-((1-((S)-1-((S)-2-((1-(4-amino-3-chlorophenyl)methanoyl)amino)-3,3-dimethyl-butanoyl)pyrrolidin-2yl)methanoyl)amino)-4-oxo-butyric acid; 1-((2S)-2-((4-amino-3-chlorobenzoyl)amino)-3,3-dimethylbutanoyl)-N-((2R,3S)-2- ethoxy-5-oxo-tetrahydrofuran-3-yl)-l-prolinamide; L-prolinamide, N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-((1S)-2-carboxy-1-formylethyl)-; N-(4-amino-3-chlorobenzoyl)-3-methyl-L-valyl-N-((1S)-2-carboxy-1-formylethyl)-L-prolinamide; O-desethyl-belnacasan; VRT 043198; VRT-043198; VX 765; VX-765; VX-765 hemiketal; VX765
Registry Numbers: 00OLE78529; 0; Q257O24H4J
Related Numbers: Q257O24H4J
Previous Indexing: P-AMINOBENZOIC ACID/*AA (2007-2012)
Heading Mapped to: *Dipeptides; *para-Aminobenzoates
Frequency: 52
Note: a NSAID
Source: J Pharmacol Exp Ther 2007 May;321(2):509-16
Date of Entry: 2007/06/03
Revision Date: 2022/10/24

belnacasan MeSH Supplementary Concept Data 2025